Basic Information
| LncRNA/CircRNA Name | pancEts-1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR, Northern blotting, Luciferase reporter assay, western blot |
| Sample | cell lines (gastric cancer MKN-45 (JCRB0254), MKN-74 (JCRB0255), NCI-N87 (CRL-5822), and AGS (CRL-1739)) |
| Expression Pattern | up-regulated |
| Function Description | Overall, these results demonstrate that lncRNA pancEts-1 exhibitsoncogenic properties that drive the progression of gastric cancer via regulating the NONO/ERG/Ets-1 axis. |
| Pubmed ID | 29773901 |
| Year | 2018 |
| Title | Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression |
External Links
| Links for pancEts-1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |